Durvalumab (D) plus platinum-etoposide (EP) in first-line extensive-stage SCLC (ES SCLC): Effect of age and platinum agent on outcomes in CASPIAN


Creative Commons License

Reinmuth N., Goldman J. W., Chen Y., Hotta K., Statsenko G., Hochmair M. J., ...More

Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), ELECTR NETWORK, 9 - 13 September 2022, vol.33 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 33
  • Doi Number: 10.1016/j.annonc.2022.07.1625
  • Country: ELECTR NETWORK
  • Istanbul University Affiliated: No